Trial intelligence / Profile preview

Preoperative Gabapentin for Pain Management in Third Molar Extractions

NCT04860141Phase 4Recruiting

Sponsor
Loma Linda University
Start
Jun 2021
Primary completion
Dec 2026
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in postoperative pain comparing Gabapentin group with Placebo group (2 arms). Primary endpoints: Postoperative Opioid Use at 72 hours and Intraoperative Fentanyl Use. Started Jun 2021; status: recruiting.

02

Drugs

gabapentin
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT04860141.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04860141.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call